1 |
A-623 or amg 623 |
- |
- |
- |
- |
066 [1] 66 💬 |
2 |
A07ea06 |
- |
- |
- |
- |
066 [1] 66 💬 |
3 |
Abelmoschus manihot |
- |
- |
- |
- |
066 [1] 66 💬 |
4 |
Ace inhibitor |
- |
- |
- |
- |
066 [1] 66 💬 |
5 |
Ace inhibitor + statin |
- |
- |
- |
- |
066 [1] 66 💬 |
6 |
Ace inhibitor or angiotensin receptor antagonist |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
7 |
Ace/arb |
- |
- |
- |
- |
066 [1] 66 💬 |
8 |
Acei |
- |
- |
- |
- |
066 [2] 66, 224 💬 |
9 |
Acei/arb and corticosteroids |
- |
- |
- |
- |
066 [1] 66 💬 |
10 |
Acteoside |
Acteoside |
- |
- |
- |
066 [1] 66 💬 |
11 |
Acth |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 [5] 13, 66, 145, 193, 222 💬 |
12 |
Acth (acthar) gel |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
066 [1] 66 💬 |
13 |
Acthar |
- |
- |
- |
- |
002 [9] 2 , 13, 14, 46, 49, 50, 66, 84, 222 💬 |
14 |
Acthar 80 unit injection |
- |
- |
- |
- |
066 [1] 66 💬 |
15 |
Aliskiren |
Aliskiren |
[1] D03208 D03208 💬 |
REN [1] REN 💬 |
Diabetic cardiomyopathy [3] Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system |
066 [4] 66, 167, 222, 223 💬 |
16 |
Allopurinol |
Allopurinol |
[1] D00224 D00224 💬 |
XDH [1] XDH 💬 |
Caffeine metabolism [5] Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 [6] 6 , 46, 57, 66, 96, 97 💬 |
17 |
Aln-cc5 |
- |
- |
- |
- |
062 [3] 62, 66, 109 💬 |
18 |
Angiotensin |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [7] 17, 19, 46, 66, 86, 222, 224 💬 |
19 |
Angiotensin blockade |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
20 |
Angiotensin ii |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [2] 66, 222 💬 |
21 |
Apl-2 |
- |
- |
- |
- |
061 [5] 61, 62, 66, 222, 223 💬 |
22 |
Arb |
- |
- |
- |
- |
066 [1] 66 💬 |
23 |
Artesunate |
Artesunate |
[1] D02482 D02482 💬 |
- |
- |
066 [1] 66 💬 |
24 |
Atacicept |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [4] 13, 46, 49, 66 💬 |
25 |
Atacicept 25 mg |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [2] 13, 66 💬 |
26 |
Atacicept 75 mg |
Atacicept |
[1] D09704 D09704 💬 |
TNFSF13 [2] TNFSF13, TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
013 [3] 13, 49, 66 💬 |
27 |
Atacicept150mg |
- |
- |
- |
- |
066 [1] 66 💬 |
28 |
Atacicept25mg |
- |
- |
- |
- |
066 [1] 66 💬 |
29 |
Atacicept75mg |
- |
- |
- |
- |
066 [1] 66 💬 |
30 |
Atg-f |
- |
- |
- |
- |
066 [1] 66 💬 |
31 |
Atrasentan |
Atrasentan |
- |
- |
- |
066 [3] 66, 218, 222 💬 |
32 |
Avb-s6-500 |
- |
- |
- |
- |
066 [1] 66 💬 |
33 |
Azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
006 [20] 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
34 |
Bardoxolone |
Bardoxolone |
[1] D09584 D09584 💬 |
- |
- |
066 [7] 66, 67, 84, 85, 86, 218, 222 💬 |
35 |
Bardoxolone methyl |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
066 [7] 66, 67, 84, 85, 86, 218, 222 💬 |
36 |
Bardoxolone methyl capsules |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
066 [4] 66, 67, 86, 222 💬 |
37 |
Belimumab |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 [10] 11, 43, 44, 46, 49, 51, 53, 66, 222, 300 💬 |
38 |
Benlysta |
- |
- |
- |
- |
043 [5] 43, 49, 53, 66, 222 💬 |
39 |
Benlysta® (belimumab) |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
011 [3] 11, 66, 222 💬 |
40 |
Bion-1301 multiple doses |
- |
- |
- |
- |
066 [1] 66 💬 |
41 |
Bion-1301 single dose |
- |
- |
- |
- |
066 [1] 66 💬 |
42 |
Blisibimod |
Blisibimod |
[1] D10311 D10311 💬 |
- |
- |
043 [5] 43, 44, 49, 63, 66 💬 |
43 |
Blisibimod injection |
Blisibimod |
[1] D10311 D10311 💬 |
- |
- |
066 [1] 66 💬 |
44 |
Blood sample |
- |
- |
- |
- |
008 [13] 8 , 13, 46, 49, 51, 53, 61, 66, 84, 97, 274, 288, 299 💬 |
45 |
Bortezomib |
Bortezomib |
[1] D03150 D03150 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
011 [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬 |
46 |
Bortezomib (velcade®) |
Bortezomib |
[1] D03150 D03150 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
066 [1] 66 💬 |
47 |
Budesonide |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [9] 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
48 |
Calcitriol |
Calcitriol |
[1] D00129 D00129 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 [8] 37, 46, 49, 66, 96, 158, 235, 326 💬 |
49 |
Ccx168 |
- |
- |
- |
- |
043 [6] 43, 44, 66, 109, 222, 223 💬 |
50 |
Cemdisiran |
Cemdisiran |
- |
- |
- |
066 [2] 66, 109 💬 |
51 |
Chinese herb prescription granule plus prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
52 |
Cilazapril |
Cilazapril |
[2] D01069 D01069, D07699 D07699 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
066 [1] 66 💬 |
53 |
Corticosteroid |
- |
- |
- |
- |
013 [10] 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
54 |
Corticotherapy |
- |
- |
- |
- |
066 [1] 66 💬 |
55 |
Cyclophosphamid |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
066 [1] 66 💬 |
56 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
57 |
Decortin h |
- |
- |
- |
- |
066 [3] 66, 97, 145 💬 |
58 |
Dipyridamole |
Dipyridamole |
[1] D00302 D00302 💬 |
PDE4A [2] PDE4A, PDE5A 💬 |
Metabolic pathways [6] Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 [5] 46, 49, 51, 66, 224 💬 |
59 |
Enalapril |
Enalapril |
[2] D00621 D00621, D07892 D07892 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 [7] 19, 46, 66, 113, 210, 222, 223 💬 |
60 |
Enalapril valsartan methylprednisone |
Enalapril |
[3] D00400 D00400, D00621 D00621, D07892 D07892 💬 |
ACE [2] ACE, AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [18] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
61 |
Fecal microbiota transplantation |
- |
- |
- |
- |
002 [5] 2 , 66, 94, 96, 97 💬 |
62 |
Fish oil |
Fish oil |
- |
- |
- |
013 [7] 13, 46, 49, 66, 96, 260, 299 💬 |
63 |
Fos |
- |
- |
- |
- |
066 [2] 66, 96 💬 |
64 |
Fostamatinib |
Fostamatinib |
[1] D09347 D09347 💬 |
SYK [1] SYK 💬 |
B cell receptor signaling pathway [17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
046 [4] 46, 49, 61, 66 💬 |
65 |
Fostamatinib 100 mg |
Fostamatinib |
[1] D09347 D09347 💬 |
SYK [1] SYK 💬 |
B cell receptor signaling pathway [17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 [1] 66 💬 |
66 |
Fostamatinib 100 mg tablet |
Fostamatinib |
[1] D09347 D09347 💬 |
SYK [1] SYK 💬 |
B cell receptor signaling pathway [17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 [1] 66 💬 |
67 |
Fostamatinib 150 mg |
Fostamatinib |
[1] D09347 D09347 💬 |
SYK [1] SYK 💬 |
B cell receptor signaling pathway [17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 [1] 66 💬 |
68 |
Fostamatinib 150 mg tablet |
Fostamatinib |
[1] D09347 D09347 💬 |
SYK [1] SYK 💬 |
B cell receptor signaling pathway [17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 [1] 66 💬 |
69 |
Fostamatinib disodium |
Fostamatinib |
[1] D09347 D09347 💬 |
SYK [1] SYK 💬 |
B cell receptor signaling pathway [17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
046 [3] 46, 61, 66 💬 |
70 |
Fostamatinib disodium tablet 100 mg |
Fostamatinib |
[1] D09347 D09347 💬 |
SYK [1] SYK 💬 |
B cell receptor signaling pathway [17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 [1] 66 💬 |
71 |
Fostamatinib disodium tablet 150 mg |
Fostamatinib |
[1] D09347 D09347 💬 |
SYK [1] SYK 💬 |
B cell receptor signaling pathway [17] B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Coronavirus disease - COVID-19, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Osteoclast differentiation, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Platelet activation, Tuberculosis, Viral carcinogenesis |
066 [1] 66 💬 |
72 |
Gastrus |
- |
- |
- |
- |
066 [1] 66 💬 |
73 |
Gsk1550188 |
- |
- |
- |
- |
011 [4] 11, 49, 66, 222 💬 |
74 |
High dose-vis649 |
- |
- |
- |
- |
066 [1] 66 💬 |
75 |
Hormone (prednisone) |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
76 |
Human soluble recombinant fc-gamma receptor iib |
- |
- |
- |
- |
066 [1] 66 💬 |
77 |
Hydroxychloroquine |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
013 [23] 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
78 |
Hydroxychloroquine sulfate |
Hydroxychloroquine |
[1] D08050 D08050 💬 |
- |
- |
046 [2] 46, 66 💬 |
79 |
Immunosuppressants |
- |
- |
- |
- |
066 [1] 66 💬 |
80 |
Immunosuppressive treatment |
- |
- |
- |
- |
066 [1] 66 💬 |
81 |
Infusion of adr-001 (mesenchymal stem cell) |
- |
- |
- |
- |
066 [1] 66 💬 |
82 |
Inhibace/cozaar |
- |
- |
- |
- |
066 [1] 66 💬 |
83 |
Intervention for incipient patients at low risk of disease progression |
- |
- |
- |
- |
066 [1] 66 💬 |
84 |
Intervention for patients at high risk of disease progression |
- |
- |
- |
- |
066 [1] 66 💬 |
85 |
Intravenous rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
066 [1] 66 💬 |
86 |
Ionis-fb-lrx |
- |
- |
- |
- |
066 [1] 66 💬 |
87 |
Iptacopan |
Iptacopan |
- |
- |
- |
066 [1] 66 💬 |
88 |
Irbesartan |
Irbesartan |
[1] D00523 D00523 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [4] 66, 167, 168, 222 💬 |
89 |
Irbesartan approved in the netherlands |
Irbesartan |
[1] D00523 D00523 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
90 |
Irbesartan tablets |
Irbesartan |
[1] D00523 D00523 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [2] 66, 222 💬 |
91 |
Irbesartan tablets (approved in the usa. reference listed drug avapro) ndc # 43547-0374-03 |
Irbesartan |
[1] D00523 D00523 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [2] 66, 222 💬 |
92 |
Irbesartan tablets (ndc# 0955-1041-90 approved in the usa) |
Irbesartan |
[1] D00523 D00523 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
93 |
Irbesartan tablets (ndc# 43547-375-50 approved in the usa) generic tablets distributed by solco healthcare us, llc |
Irbesartan |
[1] D00523 D00523 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
94 |
Leflunomide |
Leflunomide |
[1] D00749 D00749 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
011 [10] 11, 40, 46, 49, 53, 66, 162, 224, 271, 300 💬 |
95 |
Leflunomide 20 mg+prednisone 0.5mg/kg/d |
Leflunomide |
[2] D00473 D00473, D00749 D00749 💬 |
DHODH [2] DHODH, NR3C1 💬 |
Biosynthesis of cofactors [4] Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism |
066 [1] 66 💬 |
96 |
Lisinopril |
Lisinopril |
[2] D00362 D00362, D08131 D08131 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
019 [7] 19, 46, 49, 66, 67, 113, 222 💬 |
97 |
Lnp023 |
- |
- |
- |
- |
062 [3] 62, 66, 222 💬 |
98 |
Losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
99 |
Low antigen content diet |
- |
- |
- |
- |
066 [1] 66 💬 |
100 |
Low dose-vis649 |
- |
- |
- |
- |
066 [1] 66 💬 |
101 |
Medium dose-vis649 |
- |
- |
- |
- |
066 [1] 66 💬 |
102 |
Menatetrenone |
Menatetrenone |
[1] D00100 D00100 💬 |
- |
- |
066 [1] 66 💬 |
103 |
Methylprednisolon |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [4] 13, 14, 51, 66 💬 |
104 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
105 |
Methylprednisolone (mp) or prednisone (pred) |
Methylprednisolone |
[7] D00407 D00407, D00473 D00473, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
106 |
Methylprednisolone mylan générique |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
107 |
Methylprednisolone pulse |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [2] 66, 220 💬 |
108 |
Methylprednisolone(intravenously in the 1st-2nd-3rd month ) |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
109 |
Methylprednisolone(intravenously in the 1st-3rd-5th month) |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
110 |
Methylprednisone |
Methylprednisone |
- |
- |
- |
046 [3] 46, 66, 222 💬 |
111 |
Mizoribine |
Mizoribine |
[1] D01392 D01392 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
046 [8] 46, 49, 51, 53, 66, 94, 222, 224 💬 |
112 |
Mmf |
- |
- |
- |
- |
013 [13] 13, 35, 40, 49, 50, 51, 60, 65, 66, 222, 224, 226, 299 💬 |
113 |
Multi-glycoside of tripterygium wilfordii hook. f. (twh) |
Tripterygium wilfordii whole |
- |
- |
- |
066 [1] 66 💬 |
114 |
Mycophenolat-natrium |
- |
- |
- |
- |
066 [1] 66 💬 |
115 |
Mycophenolate |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [34] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
116 |
Mycophenolate mofetil |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 [32] 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
117 |
Mycophenolate mofetil (mmf) |
Mycophenolate mofetil |
[4] D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
013 [7] 13, 49, 51, 60, 65, 66, 222 💬 |
118 |
Mycophenolate mofetil plus lower dose of prednisone |
Mycophenolate mofetil |
[5] D00473 D00473, D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 [3] IMPDH1, IMPDH2, NR3C1 💬 |
Drug metabolism - other enzymes [4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism |
066 [1] 66 💬 |
119 |
Mycophenolate sodium |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
053 [3] 53, 66, 222 💬 |
120 |
Mycophenolic acid |
Mycophenolic acid |
[1] D05096 D05096 💬 |
IMPDH1 [2] IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes [3] Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 [8] 11, 43, 49, 51, 60, 66, 96, 222 💬 |
121 |
Mycophenolic sodium |
- |
- |
- |
- |
066 [2] 66, 222 💬 |
122 |
Myfortic |
- |
- |
- |
- |
049 [5] 49, 66, 162, 222, 228 💬 |
123 |
Myfortic 180mg tablets |
- |
- |
- |
- |
066 [2] 66, 222 💬 |
124 |
Myfortic 360mg tablets |
- |
- |
- |
- |
066 [2] 66, 222 💬 |
125 |
Narsoplimab |
Narsoplimab |
[1] D11531 D11531 💬 |
MASP2 [1] MASP2 💬 |
Complement and coagulation cascades [3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
066 [3] 66, 222, 223 💬 |
126 |
Nefecon |
- |
- |
- |
- |
066 [1] 66 💬 |
127 |
Omega-3 |
Omega-3 fatty acids |
- |
- |
- |
013 [7] 13, 46, 49, 66, 79, 96, 299 💬 |
128 |
Omega-3 fatty acid |
Omega-3 fatty acids |
- |
- |
- |
046 [2] 46, 66 💬 |
129 |
Omega-3 fatty acid ethylester90 |
Omega-3 fatty acids |
- |
- |
- |
066 [1] 66 💬 |
130 |
Omega-3 fatty acid fish oil supplement |
Fish oil |
- |
- |
- |
066 [1] 66 💬 |
131 |
Oms721 |
- |
- |
- |
- |
064 [3] 64, 66, 109 💬 |
132 |
Oms721 (narsoplimab) |
Narsoplimab |
[1] D11531 D11531 💬 |
MASP2 [1] MASP2 💬 |
Complement and coagulation cascades [3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection |
066 [3] 66, 222, 223 💬 |
133 |
Opl-ccl2-lpm |
- |
- |
- |
- |
066 [1] 66 💬 |
134 |
Other: continue their usual therapy |
- |
- |
- |
- |
066 [1] 66 💬 |
135 |
Other: intensive supportive care |
- |
- |
- |
- |
066 [1] 66 💬 |
136 |
Other: optimized supportive care |
- |
- |
- |
- |
066 [1] 66 💬 |
137 |
Other: vehicle (d5w or saline) |
- |
- |
- |
- |
066 [1] 66 💬 |
138 |
Over-encapsulated 150 mg irbesartan tablets |
Irbesartan |
[1] D00523 D00523 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
139 |
Over-encapsulated irbesartan |
Irbesartan |
[1] D00523 D00523 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
140 |
Over-encapsulated irbesartan tablets |
Irbesartan |
[1] D00523 D00523 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [2] 66, 222 💬 |
141 |
Paricalcitol |
Paricalcitol |
[1] D00930 D00930 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
019 [3] 19, 66, 218 💬 |
142 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
143 |
Potassium |
Potassium |
[1] D08403 D08403 💬 |
- |
- |
036 [10] 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬 |
144 |
Prednisolon |
- |
- |
- |
- |
046 [6] 46, 50, 51, 66, 96, 97 💬 |
145 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
146 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
147 |
Prednisone + inhibace/cozaar |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
148 |
Prednisone 5 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
046 [2] 46, 66 💬 |
149 |
Prednisone alone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [2] 11, 66 💬 |
150 |
Prednisone and cyclophosphamide |
Cyclophosphamide |
[3] D00287 D00287, D00473 D00473, D07760 D07760 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
151 |
Prednisone arrow 20mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
152 |
Prednisone arrow 5 mg |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
153 |
Prednisone in full dose |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
154 |
Prednisone or prednisolone |
Prednisolone |
[9] D00472 D00472, D00473 D00473, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
155 |
Prednisone plus cyclophosphamide |
Cyclophosphamide |
[3] D00287 D00287, D00473 D00473, D07760 D07760 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
066 [1] 66 💬 |
156 |
Probucol |
Probucol |
[1] D00476 D00476 💬 |
- |
- |
066 [1] 66 💬 |
157 |
Procedure: plasma exchange (pe) |
- |
- |
- |
- |
066 [2] 66, 220 💬 |
158 |
Protectis |
- |
- |
- |
- |
066 [1] 66 💬 |
159 |
R935788 |
- |
- |
- |
- |
046 [3] 46, 61, 66 💬 |
160 |
Ramipril |
Ramipril |
[1] D00421 D00421 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
046 [7] 46, 49, 66, 67, 113, 218, 257 💬 |
161 |
Rapamune |
- |
- |
- |
- |
002 [8] 2 , 60, 66, 67, 84, 158, 278, 280 💬 |
162 |
Ras |
- |
- |
- |
- |
006 [3] 6 , 13, 66 💬 |
163 |
Ras 2410 |
- |
- |
- |
- |
066 [1] 66 💬 |
164 |
Rc18 160mg |
- |
- |
- |
- |
011 [3] 11, 13, 66 💬 |
165 |
Rc18 240mg |
- |
- |
- |
- |
013 [2] 13, 66 💬 |
166 |
Re-021 |
- |
- |
- |
- |
066 [2] 66, 222 💬 |
167 |
Reh-acteoside |
Acteoside |
- |
- |
- |
066 [1] 66 💬 |
168 |
Renin angiotensin system (ras) blockade |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
169 |
Risedronate |
Risedronic acid |
[3] D00942 D00942, D03234 D03234, D08484 D08484 💬 |
FDPS [1] FDPS 💬 |
Human T-cell leukemia virus 1 infection [4] Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 [6] 46, 50, 66, 96, 113, 274 💬 |
170 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
171 |
Simulect |
- |
- |
- |
- |
066 [2] 66, 97 💬 |
172 |
Simvastatin |
Simvastatin |
[1] D00434 D00434 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [21] 6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬 |
173 |
Sirolimus |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 [35] 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
174 |
Sirolimus (study drug)+ace inhibitor + statin |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
066 [1] 66 💬 |
175 |
Sm101 |
- |
- |
- |
- |
049 [3] 49, 63, 66 💬 |
176 |
Sparsentan |
Sparsentan |
[1] D11776 D11776 💬 |
AGTR1 [2] AGTR1, EDNRA 💬 |
AGE-RAGE signaling pathway in diabetic complications [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
066 [2] 66, 222 💬 |
177 |
Sparsentan tablets |
Sparsentan |
[1] D11776 D11776 💬 |
AGTR1 [2] AGTR1, EDNRA 💬 |
AGE-RAGE signaling pathway in diabetic complications [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
178 |
Sparsentan tablets/ over-encapsulated sparsentan tablets |
Sparsentan |
[1] D11776 D11776 💬 |
AGTR1 [2] AGTR1, EDNRA 💬 |
AGE-RAGE signaling pathway in diabetic complications [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
179 |
Sparsentan tablets/over-encapsulated sparsentan tablets |
Sparsentan |
[1] D11776 D11776 💬 |
AGTR1 [2] AGTR1, EDNRA 💬 |
AGE-RAGE signaling pathway in diabetic complications [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
180 |
Sparsentan tablets/overencapsulated sparsentan tablets |
Sparsentan |
[1] D11776 D11776 💬 |
AGTR1 [2] AGTR1, EDNRA 💬 |
AGE-RAGE signaling pathway in diabetic complications [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
066 [1] 66 💬 |
181 |
Steroids |
- |
- |
- |
- |
046 [7] 46, 50, 51, 63, 66, 96, 97 💬 |
182 |
Steroids plus azathioprine |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
066 [1] 66 💬 |
183 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 [25] 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
184 |
Supportive and immunosuppressive therapy |
- |
- |
- |
- |
066 [1] 66 💬 |
185 |
Supportive therapy |
- |
- |
- |
- |
066 [1] 66 💬 |
186 |
Supportive therapy with: ace-inhibitor / arb / statin |
- |
- |
- |
- |
066 [1] 66 💬 |
187 |
Tacrolimus |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 [32] 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
188 |
Tailored diet |
- |
- |
- |
- |
066 [1] 66 💬 |
189 |
Telmisartan |
Telmisartan |
[1] D00627 D00627 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
066 [2] 66, 67 💬 |
190 |
The yi-qi-qing-jie herbal compound |
- |
- |
- |
- |
066 [1] 66 💬 |
191 |
Tripterygium |
Tripterygium wilfordii whole |
- |
- |
- |
046 [8] 46, 66, 67, 96, 162, 222, 224, 271 💬 |
192 |
Tripterygium wilfordii |
Tripterygium wilfordii whole |
- |
- |
- |
046 [6] 46, 66, 67, 222, 224, 271 💬 |
193 |
Tripterygium wilfordii (tw) |
Tripterygium wilfordii whole |
- |
- |
- |
066 [2] 66, 222 💬 |
194 |
Valsartan |
Valsartan |
[1] D00400 D00400 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 [7] 57, 58, 66, 75, 218, 222, 224 💬 |
195 |
Vis649 |
- |
- |
- |
- |
066 [1] 66 💬 |
196 |
Warfarin |
Warfarin |
[3] D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 [2] NQO1, VKORC1 💬 |
Biosynthesis of cofactors [6] Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 [11] 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
197 |
Wm (shentong granules) |
- |
- |
- |
- |
066 [1] 66 💬 |
198 |
lnp023 hydrochloride salt |
- |
- |
- |
- |
062 [3] 62, 66, 222 💬 |